Global Market Study on Glycobiology: Rising Application of Glycobiology Enzymes for Novel Drug Development to Boost the Demand during the Forecast Period


  • Published On : Jul-2016 |
  • Pages : 211 Pages |
  • Format :

Report Description:

Glycobiology is a branch of biology that deals with study of structure, function, and biosynthesis of saccharides (carbohydrates and carbohydrates containing molecules), which is the fundamental to all biological systems that may exist in pure form or are associated with other biological molecules to form glycoconjugates. Saccharides are ubiquitously present on cell surfaces, mediating cell interactions, and are relevant to almost all areas of biological research. Glycoconjugates and polysaccharides play a vital structural role in connective tissues. Advancements in the field of glycobiology has thrown light on various complicated biological processes linked to molecular and cellular communication, disease diagnosis and treatment, and developmental biology. Glycomics is the pursuit to decipher the information communicated by carbohydrate molecules – the carbohydrate code or glycocode.

Persistence Market Research offers forecast of the global glycobiology market between 2016 and 2024. In terms of value, the market is expected to register a CAGR of 12.8% during the forecast period. The study demonstrates market dynamics that are expected to influence the current environment and future status of the global glycobiology market over the forecast period. It includes key trends, drivers, restraints, and opportunities influencing growth of the global glycobiology market over forecast period 2016–2024. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights.

The global glycobiology market is segmented on the basis of:

  • Product Type
  • Application
  • End User
  • Region

On the basis of product type, the market is segmented as follows:

  • Instruments
  • Enzymes
  • Consumables
  • Reagent Kits

Enzymes product type segment is estimated to account for highest revenue share of 53.0% in 2016, and is expected to register a higher CAGR as compared to other product type segments during forecast period 2016–2024.

On the basis of application, the market is segmented as follows:

  • Drug Discovery and Development
  • Diagnostic Application
    • Oncology
    • Immunology
    • Others
  • Industrial Application
  • Therapeutic Application
    • Oncology
    • Immunology
    • Others
  • Others

Drug discovery and development application segment is expected to witness highest growth at a CAGR of 13.4% during the forecast period.

On the basis of end user, the market is segmented as follows:

  • Biopharmaceutical Companies
  • Research Laboratories
  • Hospitals
  • Diagnostic Centers
  • Contract Research Organizations
  • Biotechnology Industry
  • Academic Institutions
  • Others

On the basis of region/country, the market is segmented as follows:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • U.K.
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • ASEAN
    • Rest of APAC
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of MEA

North America glycobiology market is estimated to account for 44.2% revenue share in 2016, and is expected to dominate the global glycobiology market over the forecast period. APAC glycobiology market is expected to register a higher CAGR as compared to other regions.

Some key market participants included in PMR’s global glycobiology market include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.

Key features of this report

  • Drivers and restraints
  • Latest product innovations and key developments in the market
  • Analysis of business strategies of top players
  • Glycobiology market estimates and forecast

Glycobiology is the pursuit to decipher the information communicated by carbohydrate molecules – the carbohydrate code or glycocode. Glycans or carbohydrates are one of the fundamental classes of macromolecules present in biological systems, and are formed by individual sugar units called monosaccharides linked to each other in multiple ways. Glycans are involved in every aspect of biochemistry of life in a way that proteins and peptides cannot be evaluated without understanding science that deals with the study of synthesis, structural elucidation, functional property identification, and mechanism of interaction of glycans with biological molecules such as lipids and proteins. 

Glycobiology Market: Revenue Growth Expected to be Driven by Extensive Research to Study Carbohydrate Molecule Over the Forecast Period, 2016–2024

Chronic diseases such as cancer and diabetes have become a major reason for increasing research in the field of drug development, which is leading to increasing R&D expenditure by pharmaceutical companies, thus boosting revenue growth of the global glycobiology market. Increasing funding through government bodies is expected to boost revenue growth of the market over the forecast period. Factors such as continuous technological advancements, availability of products to conduct protocol with high specificity and sensitivity is expected to boost revenue growth of the global glycobiology market. However, factors such as high product cost and low availability of skilled professionals is expected to hamper revenue growth of the global glycobiology market. 

On the basis of product type, PMR has segmented the glycobiology market into instruments, enzymes, consumables, and reagent kits. Enzymes product type segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Due to high adoption rate of enzymes to conduct various research, this segment is expected to witness high incremental opportunity globally.

On the basis of end user, the glycobiology market has been segmented into biopharmaceutical companies, research laboratories, hospitals, diagnostic centers, contract research organization, biotechnology industry, academic institutes, and others. PMR estimates that biopharmaceutical companies segment is expected to account for the highest revenue share in end user segment of the global glycobiology market and is expected to witness fastest growth over the forecast period. Factors such as increasing demand for novel drug development, especially for chronic diseases such as cancer and diabetes, is expected to boost revenue share of the biopharmaceutical companies segment. Research laboratories segment is also expected to register a significant growth rate during the forecast period.

By region, the global glycobiology market is segmented into North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). The U.S. is expected to remain dominant market for glycobiology in the North America glycobiology market; whereas APAC region is expected to witness highest growth majorly due to increasing number of research initiatives being conducted in countries such as Japan and China. 

Some key market participants included in the report include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc. 

Company Profiled

  • Merck KGaA 
  • Bio-Techne Corporation 
  • Bruker Corporation 
  • Thermo Fisher Scientific, Inc. 
  • Shimadzu Corporation 
  • Plexera Bioscience LLC 
  • New England Biolabs Inc. 
  • Agilent Technologies, Inc. 
  • ProZyme, Inc. 
  • Others.
Back To Top